ARTEBONE® is a patented state-of-the-art orthobiological product, based on tricalcium phosphate (TCP) and natural spectrum of bone proteins. It thus includes bone growth factors that have superior capability in bone regeneration.
ARTEBONE® solves the problems of bone healing by providing both the clinician and patient with a reliable, safe and high-performing bone substitute. By stimulating the new bone formation, it provides an effective repair of bone defects.
The demand for an adequate substitute for autograft and allograft is rapidly growing, not the least because of the ageing population. The potential market size for orthobiologics today is already approximately USD 5 billion of which bone graft substitutes account for nearly USD 3 billion.
The commonly used bone graft substitutes consist either of synthetic materials or bone materials harvested from human cadavers. ARTEBONE® fulfills properties of an ideal bone graft substitute by providing a scaffold for bone growth and by promoting new bone formation. It does not include human disease transmission and not produce superfluous bone.